[Current therapy of multiple sclerosis: value of cyclosporin A and FK 506].
Hohlfeld
R
R
Neurologische Klinik, Ludwig-Maximilians-Universität München.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents; D009103:Multiple Sclerosis / Q000188:drug therapy*; D013601:T-Lymphocytes / Q000187:drug effects; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016559:Tacrolimus
Aktuelle Therapie der multiplen Sklerose: Stellenwert von Cyclosporin A und FK 506.